US-based OrbiMed has raised $487 million so far for its fourth Asia-focused healthcare fund, according to the company’s filing with the Securities and Exchange Commission.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
